268 related articles for article (PubMed ID: 28851503)
21.
Dubey P; Pathak DP; Ali F; Chauhan G; Kalaiselvan V
Curr Drug Discov Technol; 2024; 21(2):e170723218813. PubMed ID: 37461340
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, docking studies and biological evaluation of novel dihydro-1,3,5-triazines as human DHFR inhibitors.
Zhou X; Lin K; Ma X; Chui WK; Zhou W
Eur J Med Chem; 2017 Jan; 125():1279-1288. PubMed ID: 27886545
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.
Abdel-Rahman RM; Morsy JM; Hanafy F; Amene HA
Pharmazie; 1999 May; 54(5):347-51. PubMed ID: 10368828
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel 6-hydrazinyl-2,4-bismorpholino pyrimidine and 1,3,5-triazine derivatives as potential antitumor agents.
Zhu W; Liu Y; Zhao Y; Wang H; Tan L; Fan W; Gong P
Arch Pharm (Weinheim); 2012 Oct; 345(10):812-21. PubMed ID: 22707438
[TBL] [Abstract][Full Text] [Related]
25. Di- and tri-substituted s-triazine derivatives: Synthesis, characterization, anticancer activity in human breast-cancer cell lines, and developmental toxicity in zebrafish embryos.
El-Faham A; Farooq M; Almarhoon Z; Alhameed RA; Wadaan MAM; de la Torre BG; Albericio F
Bioorg Chem; 2020 Jan; 94():103397. PubMed ID: 31706684
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and antiproliferative evaluation of pyrazolo[1,5-a]-1,3,5-triazine myoseverin derivatives.
Popowycz F; Schneider C; Debonis S; Skoufias DA; Kozielski F; Galmarini CM; Joseph B
Bioorg Med Chem; 2009 May; 17(9):3471-8. PubMed ID: 19349183
[TBL] [Abstract][Full Text] [Related]
27. Isoindolo[2,1-c]benzo[1,2,4]triazines: a new ring system with antiproliferative activity.
Diana P; Martorana A; Barraja P; Lauria A; Montalbano A; Almerico AM; Dattolo G; Cirrincione G
Bioorg Med Chem; 2007 Jan; 15(1):343-9. PubMed ID: 17064918
[TBL] [Abstract][Full Text] [Related]
28. Design and synthesis of mono-and di-pyrazolyl-s-triazine derivatives, their anticancer profile in human cancer cell lines, and in vivo toxicity in zebrafish embryos.
Farooq M; Sharma A; Almarhoon Z; Al-Dhfyan A; El-Faham A; Taha NA; Wadaan MAM; Torre BG; Albericio F
Bioorg Chem; 2019 Jun; 87():457-464. PubMed ID: 30927586
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antitumor activity of benzimidazolyl-1,3,5-triazine and benzimidazolylpyrimidine derivatives.
Matsuno T; Karo M; Sasahara H; Watanabe T; Inaba M; Takahashi M; Yaguchi SI; Yoshioka K; Sakato M; Kawashima S
Chem Pharm Bull (Tokyo); 2000 Nov; 48(11):1778-81. PubMed ID: 11086914
[TBL] [Abstract][Full Text] [Related]
30. Review of the Synthesis and Anticancer Properties of Pyrazolo[4,3-
Bernat Z; Szymanowska A; Kciuk M; Kotwica-Mojzych K; Mojzych M
Molecules; 2020 Aug; 25(17):. PubMed ID: 32872493
[TBL] [Abstract][Full Text] [Related]
31. New benzothieno[3,2-d]-1,2,3-triazines with antiproliferative activity: synthesis, spectroscopic studies, and biological activity.
Lauria A; Alfio A; Bonsignore R; Gentile C; Martorana A; Gennaro G; Barone G; Terenzi A; Almerico AM
Bioorg Med Chem Lett; 2014 Aug; 24(15):3291-7. PubMed ID: 24986661
[TBL] [Abstract][Full Text] [Related]
32. Triazine as a promising scaffold for its versatile biological behavior.
Singla P; Luxami V; Paul K
Eur J Med Chem; 2015 Sep; 102():39-57. PubMed ID: 26241876
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs, part III.
el-Gendy Z; Morsy JM; Allimony HA; Ali WR; Abdel-Rahman RM
Pharmazie; 2001 May; 56(5):376-83. PubMed ID: 11400552
[TBL] [Abstract][Full Text] [Related]
34. o-Carboranylalkoxy-1,3,5-Triazine Derivatives: Synthesis, Characterization, X-ray Structural Studies, and Biological Activity.
Jin GF; Ban HS; Nakamura H; Lee JD
Molecules; 2018 Aug; 23(9):. PubMed ID: 30200261
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of some new heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anti-cancer drugs, Part II.
Abdel-Rahman RM; Morsy JM; el-Edfawy S; Amine HA
Pharmazie; 1999 Sep; 54(9):667-71. PubMed ID: 10522270
[TBL] [Abstract][Full Text] [Related]
36. Structure-activity relationships of 1,2,4-benzotriazine 1,4-dioxides as hypoxia-selective analogues of tirapazamine.
Hay MP; Gamage SA; Kovacs MS; Pruijn FB; Anderson RF; Patterson AV; Wilson WR; Brown JM; Denny WA
J Med Chem; 2003 Jan; 46(1):169-82. PubMed ID: 12502371
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and antitumor activity of novel 2-amino-4-(3,5,5-trimethyl-2-pyrazolino)-1,3,5-triazine derivatives.
Brzozowski Z; Saczewski F
Eur J Med Chem; 2002 Sep; 37(9):709-20. PubMed ID: 12350288
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design and synthesis of novel macrocyclic pyrazolo[1,5-a] [1,3,5]triazine compounds as potent inhibitors of protein kinase CK2 and their anticancer activities.
Nie Z; Perretta C; Erickson P; Margosiak S; Lu J; Averill A; Almassy R; Chu S
Bioorg Med Chem Lett; 2008 Jan; 18(2):619-23. PubMed ID: 18055206
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and characterization of novel 1,2,4-triazine derivatives with antiproliferative activity.
Krauth F; Dahse HM; Rüttinger HH; Frohberg P
Bioorg Med Chem; 2010 Mar; 18(5):1816-21. PubMed ID: 20153202
[TBL] [Abstract][Full Text] [Related]
40. New One-Pot Synthesis of 1,3,5-Triazines: Three-Component Condensation, Dimroth Rearrangement, and Dehydrogenative Aromatization.
Junaid A; Lim FPL; Tiekink ERT; Dolzhenko AV
ACS Comb Sci; 2019 Jul; 21(7):548-555. PubMed ID: 31180634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
